1245514-96-8

Basic information

• Product Name: 6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione
• Synonyms: 6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione;6'-bromospiro[cyclohexane-1,2'-indene]-1',4(3'H)-dione;6'-bromospiro [cyclohexane-4,2'-indane]- 1,1‘-dione;6-Bromospiro[Cyclohexane-1,2-Indene]-1,4(3H)-Dione(WX633218)
• CAS NO: 1245514-96-8
• Molecular Formula: C₁₄H₁₃BrO₂
• Molecular Weight: 293.15582
• EINECS: -0
• Mol File: 1245514-96-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione(1245514-96-8)
• EPA Substance Registry System: 6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione(1245514-96-8)

Safety Data

• Hazardous Substances Data: 1245514-96-8(Hazardous Substances Data)

Usage

General Description

6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione is a chemical compound that belongs to the group of spiro compounds. It is a heterocyclic compound containing a spiro ring system, with a bromine atom attached to one of the carbon atoms. 6-bromospiro[3H-indene-2,4'-cyclohexane]-1,1'-dione has potential applications in medicinal chemistry, particularly in the development of new pharmaceuticals. Its unique structure and properties make it an interesting target for research and development in the field of drug discovery. However, further studies and investigations are needed to fully understand the potential uses and effects of this compound.

Upstream product

• 1245516-69-1 dimethyl 3,3'-(6-bromo-1-oxo-2,3-dihydro-1H-indene-2,2-diyl)dipropanoate 
• 1245516-70-4 methyl 6'-bromo-4-hydroxy-1'-oxo-1',3'-dihydrospiro[cyclohex[3]ene-1,2'-indene]-3-carboxylate 
• 14548-39-1 6-bromoindan-1-one 
• 38053-91-7 2-trimethylsilyloxy-1,3-butadiene 
• 292638-85-8 acrylic acid methyl ester 

Downstream Products

• 1383982-64-6 (1r,1’R,4R)-4-methoxy-5”-methyl-6’-[5-(prop-1-yn-1-yl)pyridin-3-yl]-3’H-dispiro[cyclohexane-1,2’-indene-1’2”-imidazol]-4”-amine 
• 1383983-89-8 3-[(1r,4r)-4''-amino-4-(difluoromethoxy)-5''-methyl-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-6'-yl]-5-fluorobenzonitrile 
• 1383985-61-2 (1r,4r)-6'-bromo-4-methoxyspiro[cyclohexane-1,2'-inden]-1'(3'H)-imine hydrochloride 
• 1383986-29-5 (1s,4s)-6'-bromo-4-methoxyspiro[cyclohexane-1,2'-inden]-1'(3'H)-imine hydrochloride 
• 1383984-00-6 3-(4-amino-5-methyl-4-oxodispiro[cyclohexane-1,2'-[1H]indene-1'(3'H),2-[2H]imidazol]-6'-yl)-5-fluorobenzonitrile 

Relevant articles and documents

COMBINATION OF A BACE INHIBITOR AND AN ANTIBODY OR ANTIGEN-BINDING FRAGMENT FOR THE TREATMENT OF A DISORDER ASSOCIATED WITH THE ACCUMULATION OF AMYLOID BETA

The present disclosure provides for methods for treating a subject having a disease or disorder associated with the accumulation of amyloid beta, comprising administering to the subject a BACE inhibitor and an antibody or antigen-binding fragment that binds to amyloid beta n-42. In some embodiments, the disease or disorder is Alzheimer's Disease.

CYCLOALKYL ETHER COMPOUNDS AND THEIR USE AS BACE INHIBITORS

Cycloalkyl ether compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating Αβ-related pathologies such as Down's syndrome, β-amyloid angiopathy, Alzheimer's disease, memory loss

MONO-FLUORO BETA-SECRETASE INHIBITORS

Beta-secretase inhibitors, of formula (I) as described in the specification, pharmaceutical compositions comprising them and therapeutic methods using them for the treatment and/or prevention of Αβ-related pathologies such as Down's syndrome, β-amyloid an